Haematologica · 2019 · 70 citations · 26 references
MedicineBiostatisticsHematologyHematologic OncologySurvival AnalysisTransfusion MedicineBlood Component TherapyBlood Transfusion ManagementMyelodysplastic SyndromesRed Blood Cell TransfusionTransfusion SupportTransfusion TherapyAcute Myeloid Leukemia ProgressionBone Marrow Differential CountCytogenetic Risk StratificationDose DensityHigher-risk Myelodysplastic SyndromesLower-risk Myelodysplastic SyndromesMyelodysplastic Syndrome TherapyProspective Cohort Data
Progression-free survival (PFS) of patients with lower-risk myelodysplastic syndromes (MDS) treated with red blood cell transfusions is usually reduced, but it is unclear whether transfusion dose density is an independent prognostic factor. The European MDS Registry collects prospective data at 6-monthly intervals from newly diagnosed lower-risk myelodysplastic syndromes patients in 16 European countries and Israel. Data on the transfusion dose density - the cumulative dose received at the end of each interval divided by the time since the beginning of the interval in which the first transfusion was received - were analyzed using proportional hazards regression with time-varying co-variates, with death and progression to higher-risk MDS/acute myeloid leukemia as events. Of the 1,267 patients included in the analyses, 317 died without progression; in 162 patients the disease had progressed. PFS was significantly associated with age, EQ-5D index, baseline World Health Organization classification, bone marrow blast count, cytogenetic risk category, number of cytopenias, and country. Transfusion dose density was inversely associated with PFS (P
26
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text
Luca Malcovati, Matteo Giovanni Della Porta, Cristiana Pascutto et al. · Journal of Clinical Oncology · 2005 · 860 citations · Full text
Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag et al. · Blood · 2011 · 480 citations · Full text
Medicine, Hematology, Pharmacology +14